ACADIAN ASSET MANAGEMENT LLC

Position in OLMA — Olema Pharmaceuticals, Inc.

CIK 916542 Boston, MA

Position in OLMA

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$10,750

-$466,450 QoQ

Shares Held

721

-96.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,664,999	$188,744,286
2	REGN	Regeneron Pharmaceuticals, Inc.	157,440	$98,170,137
3	IMCR	Immunocore Holdings plc	1,209,894	$38,414,134
4	RIGL	Rigel Pharmaceuticals Inc	591,686	$23,146,756
5	EXEL	Exelixis, Inc.	421,444	$22,930,768
6	VRTX	Vertex Pharmaceuticals Inc / Ma	42,122	$20,923,261
7	TBPH	Theravance Biopharma, Inc.	1,174,910	$19,973,470
8	PRTA	Prothena Corp Public Ltd Co	2,010,645	$19,684,214

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,750	721	-96.2%	Shares	Defined	2026-05-13
2025-12-31	$477,200	19,088	-81.5%	Shares	Defined	2026-02-10
2024-03-31	$1,167,986	103,179	-59.7%	Shares	Defined	2024-05-10
2023-12-31	$3,590,627	255,925	-48.1%	Shares	Defined	2024-02-13
2023-09-30	$6,087,080	492,881	-14.9%	Shares	Defined	2023-11-13
2023-06-30	$5,231,160	579,309	+0.6%	Shares	Defined	2023-08-07
2023-03-31	$1,998,373	575,900	0.0%	Shares	Defined	2023-05-11
2022-12-31	$1,410,955	575,900	+0.5%	Shares	Defined	2023-02-14
2022-09-30	$1,581,416	572,977	+22.9%	Shares	Defined	2022-11-14
2022-06-30	$1,897,295	466,166	+305.1%	Shares	Defined	2022-08-09
2022-03-31	$490,223	115,076	+14.4%	Shares	Defined	2022-05-12
2021-12-31	$941,821	100,622	—	Shares	Defined	2022-02-10
No filing history on record for this holder in this stock.